These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 19722166)

  • 41. Dose-independent pharmacokinetics of metformin in rats: Hepatic and gastrointestinal first-pass effects.
    Choi YH; Kim SG; Lee MG
    J Pharm Sci; 2006 Nov; 95(11):2543-52. PubMed ID: 16937336
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In silico modeling for the nonlinear absorption kinetics of UK-343,664: a P-gp and CYP3A4 substrate.
    Abuasal BS; Bolger MB; Walker DK; Kaddoumi A
    Mol Pharm; 2012 Mar; 9(3):492-504. PubMed ID: 22264132
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetics and first-pass effects of liquiritigenin in rats: low bioavailability is primarily due to extensive gastrointestinal first-pass effect.
    Kang HE; Cho YK; Jung HY; Choi KY; Sohn SI; Baek SR; Lee MG
    Xenobiotica; 2009 Jun; 39(6):465-75. PubMed ID: 19480552
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dose-independent pharmacokinetics of a new reversible proton pump inhibitor, KR-60436, after intravenous and oral administration to rats: gastrointestinal first-pass effect.
    Yu SY; Bae SK; Kim EJ; Kim YG; Kim SO; Lee DH; Lim H; Lee MG
    J Pharm Sci; 2003 Aug; 92(8):1592-603. PubMed ID: 12884246
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dose-dependent pharmacokinetics of itraconazole after intravenous or oral administration to rats: intestinal first-pass effect.
    Shin JH; Choi KY; Kim YC; Lee MG
    Antimicrob Agents Chemother; 2004 May; 48(5):1756-62. PubMed ID: 15105131
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improved blood-brain barrier distribution: effect of borneol on the brain pharmacokinetics of kaempferol in rats by in vivo microdialysis sampling.
    Zhang Q; Wu D; Wu J; Ou Y; Mu C; Han B; Zhang Q
    J Ethnopharmacol; 2015 Mar; 162():270-7. PubMed ID: 25582491
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Disposition of SK&F L-190144 in rats and monkeys after oral, intravenous or ocular administration.
    Tang-Liu DD; Richman JB; Lin P; Selim S
    Biopharm Drug Dispos; 1993 May; 14(4):313-24. PubMed ID: 8499582
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dose-independent pharmacokinetics of a candidate for diabetic neuropathy, SR-4668, after intravenous and oral administration to rats: Intestinal first-pass effect.
    Kim EJ; Bae SK; Kim HJ; Kim YG; Kim SO; Lee DH; Lim H; Lee MG
    J Pharm Sci; 2003 May; 92(5):1112-24. PubMed ID: 12712431
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A pharmacokinetic model for evaluating the impact of hepatic and intestinal first-pass loss of saquinavir in the rat.
    Lledó-García R; Nácher A; Casabó VG; Merino-Sanjuán M
    Drug Metab Dispos; 2011 Feb; 39(2):294-301. PubMed ID: 20978105
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A phospholipid complex to improve the oral bioavailability of flavonoids.
    Wang H; Cui Y; Fu Q; Deng B; Li G; Yang J; Wu T; Xie Y
    Drug Dev Ind Pharm; 2015; 41(10):1693-703. PubMed ID: 25496311
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preparation and evaluation of kaempferol-phospholipid complex for pharmacokinetics and bioavailability in SD rats.
    Zhang K; Gu L; Chen J; Zhang Y; Jiang Y; Zhao L; Bi K; Chen X
    J Pharm Biomed Anal; 2015 Oct; 114():168-75. PubMed ID: 26051640
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Absorption of kaempferol from endive, a source of kaempferol-3-glucuronide, in humans.
    DuPont MS; Day AJ; Bennett RN; Mellon FA; Kroon PA
    Eur J Clin Nutr; 2004 Jun; 58(6):947-54. PubMed ID: 15164116
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dose-dependent pharmacokinetics of a new reversible proton pump inhibitor, DBM-819, after intravenous and oral administration to rats: hepatic first-pass effect.
    Kim EJ; Kim SO; Lee DH; Lim H; Lee MG
    Biopharm Drug Dispos; 2001 Apr; 22(3):119-28. PubMed ID: 11745914
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The use of 1-aminobenzotriazole in differentiating the role of CYP-mediated first pass metabolism and absorption in limiting drug oral bioavailability: a case study.
    El-Kattan AF; Poe J; Buchholz L; Thomas HV; Brodfuehrer J; Clark A
    Drug Metab Lett; 2008 Apr; 2(2):120-4. PubMed ID: 19356080
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The characteristics and mechanism of co-administration of lovastatin solid dispersion with kaempferol to increase oral bioavailability.
    Li J; Di L; Cheng X; Ji W; Piao H; Cheng G; Zou M
    Xenobiotica; 2020 May; 50(5):593-601. PubMed ID: 31505985
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sensitive determination of kaempferol in rat plasma by high-performance liquid chromatography with chemiluminescence detection and application to a pharmacokinetic study.
    Zhang Q; Zhang Y; Zhang Z; Lu Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Nov; 877(29):3595-600. PubMed ID: 19748328
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glucosamine modulates propranolol pharmacokinetics via intestinal permeability in rats.
    Al Shaker HA; Qinna NA; Badr M; Al Omari MMH; Idkaidek N; Matalka KZ; Badwan AA
    Eur J Pharm Sci; 2017 Jul; 105():137-143. PubMed ID: 28502673
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hydroxypropyl-beta-cyclodextrin-flutamide inclusion complex. II. Oral and intravenous pharmacokinetics of flutamide in the rat.
    Zuo Z; Tam YK; Diakur J; Wiebe LI
    J Pharm Pharm Sci; 2002; 5(3):292-8. PubMed ID: 12553899
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dose-Dependent Pharmacokinetics of Tofacitinib in Rats: Influence of Hepatic and Intestinal First-Pass Metabolism.
    Lee JS; Kim SH
    Pharmaceutics; 2019 Jul; 11(7):. PubMed ID: 31284540
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dose-independent pharmacokinetics of ondansetron in rats: contribution of hepatic and intestinal first-pass effects to low bioavailability.
    Yang SH; Lee MG
    Biopharm Drug Dispos; 2008 Oct; 29(7):414-26. PubMed ID: 18697186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.